systematic_review
2018
Nattokinase: an updated critical review on challenges and perspectives
Chen H, McGowan EM, Ren N
Published in Cardiovascular Drugs and Therapy
Key Findings
Nattokinase has demonstrable fibrinolytic activity in vitro, but oral bioavailability and interaction with anticoagulants remain poorly characterised.
Conclusions
Bleeding risk with anticoagulants is the key safety concern.
Limitations
Narrative review.
Supplements Studied
Nattokinase
Enzyme
Oral bioavailability and interaction with anticoagulants remain poorly characterised.
Study Details
Year:2018
Quality Score:5/10
Access Study
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.